["{\n\"step_by_step_thinking\": \"The question asks whether Uc.63+ promotes sensitivity to treatment in prostate cancer. The relevant documents do not mention Uc.63+, which seems to be a unknown or non-existent entity in the context of prostate cancer. Therefore, it is impossible to determine if Uc.63+ promotes sensitivity to treatment.\",\n\"answer_choice\": \"B\"\n}"]